Baystate Wealth Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$19.8K Hold
110
﹤0.01% 561
2023
Q3
$17.5K Buy
110
+65
+144% +$10.6K ﹤0.01% 494
2023
Q2
$6.37K Hold
45
﹤0.01% 655
2023
Q1
$7.58K Hold
45
﹤0.01% 608
2022
Q4
$8K Hold
45
﹤0.01% 627
2022
Q3
$8K Hold
45
﹤0.01% 585
2022
Q2
$7K Hold
45
﹤0.01% 629
2022
Q1
$8K Hold
45
﹤0.01% 612
2021
Q4
$12K Hold
45
﹤0.01% 546
2021
Q3
$13K Hold
45
﹤0.01% 498
2021
Q2
$9K Hold
45
﹤0.01% 517
2021
Q1
$9K Buy
45
+43
+2,150% +$8.82K ﹤0.01% 469
2020
Q4
$0 Buy
+2
New +$364 ﹤0.01% 746

Other funds holding RGEN

Baystate Wealth Management's RGEN Position: Q4 2023 in Review

Baystate Wealth Management held its Repligen (RGEN) position steady in Q4 2023 at 110 shares worth $19.8K. The position accounts for ﹤0.01% of the portfolio, ranked #561.

Baystate Wealth Management first reported a position in RGEN in Q4 2020 and has held it in 13 quarters since. 466 funds tracked by Wall St. Rank hold RGEN as of Q4 2023.

  • Baystate Wealth Management held 110 shares of Repligen worth $19.8K as of Q4 2023.
  • Baystate Wealth Management left its Repligen share count unchanged in Q4 2023.
  • Repligen made up ﹤0.01% of Baystate Wealth Management's portfolio in Q4 2023, its #561 holding.
  • Baystate Wealth Management first reported a position in Repligen in Q4 2020 and has held it in 13 quarters since.
  • 466 funds tracked by Wall St. Rank held Repligen as of Q4 2023.

Based on Baystate Wealth Management's 13F filing for Q4 2023, filed 29 Jan 2024.